Flemming et al. showed that Dsg2 down-regulated both cellular and SEVs-loaded miR-146a in head and neck squamous cell carcinoma (HNSCC) to modulates tumour development and progression [23]. The gene discussed is DSG2; the disease is head and neck squamous cell carcinoma.